noctuRNA Therapeutics is a spin-off from Universitat Pompeu Fabra.
noctuRNA Tx has built a patented RNA-based drug platform that enables the generation of novel candidate therapeutical molecules within 2 to 4 weeks. This drug platform is based on artificial circular RNA molecules (circRNA) that efficiently disrupt pathogenic or aberrant RNA secondary structures present in several diseases. We have developed a first-in-class therapeutic approach to tackle some of the world's most intractable diseases.
Company Details
- Employees
- 5
- Founded
- -
- Address
- Carrer Del Doctor Aiguader, 88, Barcelona,catalonia 08003,spain
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://nocturnatx.com/
- HQ
- Barcelona, Catalonia
Nocturna Therapeutics Questions
Nocturna Therapeutics's website is http://nocturnatx.com/
Nocturna Therapeutics's LinkedIn profile is https://es.linkedin.com/company/nocturnatx
Nocturna Therapeutics has
5 employees.
View email and phone details for 5
employees at Nocturna Therapeutics.
Nocturna Therapeutics's industry is
Biotechnology Research
Nocturna Therapeutics's top competitors are
Point Pressure,
Succipro,
Affirma Biotech Sl,
Ivestatin Therapeutics,
Nanological,
Miramoon Pharma,
Leitat Technological Center,
Moirai Biodesign,
Telomere Therapeutics,
Nema-Health.
Nocturna Therapeutics's categories are Biotechnology Research
Nocturna Therapeutics's founding year is 2022
